Study information

Programme Specification for the 2024/5 academic year

BSc (Hons) Medical Sciences (Neuroscience)

1. Programme Details

Programme nameBSc (Hons) Medical Sciences (Neuroscience) Programme codeUFS3EMSBIO03
Study mode(s)Full Time
 Academic year2024/5
Campus(es)Streatham (Exeter)
St Luke's (Exeter)
 NQF Level of the Final Award6 (Honours)

2. Description of the Programme

Please note - this programme code is for the Neuroscience pathway within the main BSc (Hons) Medical Sciences programme.

For full programme details please refer to the core BSc (Hons) Medical Sciences programme specification: 

For the BSc (Hons) Medical Sciences (Neuroscience) pathway specific modules please see section Programme Modules here. 

 

3. Educational Aims of the Programme

 

 

4. Programme Structure

 

 

 

5. Programme Modules

BSc (Hons) Medical Sciences (Neuroscience) Pathway

Stage 1 – same as Stage 1 of the core BSC (Hons) Medical Sciences programme

Stage 1

Stage 1 – same as Stage 1 of the core BSc (Hons) Medical Sciences programme

Compulsory Modules

CodeModule Credits Non-condonable?
CSC1005 Integrated Human Physiology 30No
CSC1004 Fundamental Skills for Medical Scientists 30No
BIO1332 Biochemistry 15No
BIO1334 Genetics 15No
BIO1337 Microbiology 15No
BIO1339 Cells 15No

Stage 2

If you wish to pursue the Neuroscience pathway, you are required to take 75 credits of compulsory modules, including the 15 credit Introduction to Neuroscience module (NEU1006). A further 45 credits should be selected from the optional modules, and those developed and advertised annually on the Medical Sciences web pages, to a total of 120 credits. If you choose the Neuroscience pathway, you may wish to consider the optional module BIO2088 (Advanced Cell Biology).

Compulsory Modules

CodeModule Credits Non-condonable?
CSC2012 Disease, Diagnostics and Therapeutics (in third year for p/t students)30No
CSC2023 Experimental Design and Statistics (in fourth year for p/t students)30No
NEU1006 Introduction to Neuroscience (in third year for p/t students)15No

Optional Modules

aIf you take CSC2008 (Immunopathology), you will not be permitted to take BIO3078 (Cellular Basis of Immunity) in final year.

b You may only take one of these three optional modules: CSC2008 Immunopathology, CSC2009 Anatomical Sciences and CSC2004 Medical Genetics.

c You may only take one of these two optional modules: CSC2020 Coding for Medical Scientists, BIO2101 Advanced Microbiology and CSC2026 The Biology of Cancer.

CodeModule Credits Non-condonable?
BIO2088 Advanced Cell Biology 15No
BIO2101 Advanced Microbiology (See note c)15No
CSC2004 Medical Genetics (See note b)15No
CSC2005 Introduction to Pharmacology 15No
CSC2008 Immunopathology (See notes a,b)15No
CSC2009 Anatomical Sciences (See note b)15No
CSC2020 Coding for Medical Scientists (See note c)15No
CSC2025 Decolonising Medicine, An Introduction 15No
CSC2026 The Biology of Cancer 15No
BIO2089 Molecular Biology of the Gene 15No

Stage 3

If you wish to continue on the Neuroscience pathway, you are required to complete 120 credits at Stage 3, made up of 30 credits of compulsory modules, 45 credits from either CSC3028 or CSC3029 and at least 30 credits must be selected from the pathway-specific optional modules NEU2019 (Neuropharmacology), NEU2018 (Neural Circuits), CSC3030 (Neuroimmunology).  The remaining 15 credits may be chosen from the optional modules below, and those developed and advertised annually on the Medical Sciences webpages.

Compulsory Modules

CodeModule Credits Non-condonable?
CSC3019 Translational Medical Science (in fifth year for p/t students)30No

Optional Modules

a You must take one of these modules. You will initially be allocated to CSC3028, then transferred onto CSC3029 if appropriate following the project allocation process. For part-time students: take these modules in your final sixth year.

b  If you  took CSC2008 (Immunopathology) in second year are not permitted to take BIO3078 (Cellular Basis of Immunity) in final year.

c You may only take one of these two optional modules: NEU2019 Neuropharmacology and BIO3079 Molecular Basis of Infection

 d You must select at least 30 credits from the pathway-specific optional modules NEU2019 (Neuropharmacology), NEU2018 (Neural Circuits), NEU3030 (Neuroimmunology). 

CodeModule Credits Non-condonable?
CSC3028 Medical Sciences Literature Review (See note a)45No
CSC3029 Medical Sciences Research Project (See note a)45No
NEU2018 Neural Circuits (See note d)15No
NEU2019 Neuropharmacology (See note c,d)15No
NEU3030 Neuroimmunology (See note d)15No
BIO3078 Cellular Basis of Immunity (See note b)15No
BIO3079 Molecular Basis of Infection (See note c)15No
BIO3086 Cell Biology of Disease (See note c)15No
BIO3092 Bioinformatics 15No
CSC3010 Rational Drug Design 15No
CSC3031 Applied Data Science 15No

6. Programme Outcomes Linked to Teaching, Learning and Assessment Methods

Intended Learning Outcomes
A: Specialised Subject Skills and Knowledge

Intended Learning Outcomes (ILOs)
On successfully completing this programme you will be able to:		Intended Learning Outcomes (ILOs) will be...
...accommodated and facilitated by the following learning and teaching activities (in/out of class):...and evidenced by the following assessment methods:

1. Demonstrate an integrated and detailed knowledge and understanding of the core biomolecular and biomedical science principles underpinning human health and important diseases
2. . Demonstrate key competence in key biomedical and clinical science techniques and an understanding of key clinical methods
3. 3 Demonstrate an understanding, with associated practical applications, of the key principles underpinning audit, basic and applied clinical research (including the critical appraisal of different research strategies)
4. Demonstrate an understanding of the fundamental contemporary theoretical, cultural, ethical, and regulatory bases of basic and applied clinical research practice within the UK and wider global community contexts

Structured small group learning sessions; lectures; practical laboratory classes; experiential placements; research project or dissertation; independent study, and personal tutor feedback

LOs 1-4 will be tested across the core and optional module formative and summative assessment, including essay examinations, short answer and multiple choice tests, written reviews, practical work and projects, quantitative problems, project report/dissertation, oral and poster presentations; project supervisor judgements, and reflective portfolio analyses

Intended Learning Outcomes
B: Academic Discipline Core Skills and Knowledge

Intended Learning Outcomes (ILOs)
On successfully completing this programme you will be able to:		Intended Learning Outcomes (ILOs) will be...
...accommodated and facilitated by the following learning and teaching activities (in/out of class):...and evidenced by the following assessment methods:

5. Apply skills of critical thinking, problem-formulation, problem-solving, and rigorous scientific data handling to clinical science practice
6. Demonstrate an understanding of the key clinical science principles underpinning the prevention, diagnosis, and clinical management of important illnesses and diseases
7. Demonstrate an understanding of the key principles and challenges for healthcare planning and delivery, including the development and implementation of new health technologies
8. Demonstrate an awareness of key human science principles associated with human health, illness and disease
9. Understand and apply the expected performance standards in relation to scientific probity, multidisciplinary team-based practice, and recognise personal levels of professional scientific competence
10. 0. Apply clinical science knowledge, theory and academic skills to help advance project(s) in a professional training placement setting B: Learning and Teaching Act

 Structured small group learning sessions; lectures; practical laboratory classes; experiential placements; research project or dissertation; independent study and personal tutor feedback.

ILOs 5-10 will be tested across the core and optional module formative and summative assessment, including essay examinations, short answer and multiple choice tests, written reviews, practical work and projects, quantitative problems, project report/dissertation, oral and poster presentations; project supervisor judgements, and reflective portfolio analyses. ILO 9-10 will also be assessed using peer and facilitator (personal development and professionalism) PDP judgements in small group sessions, portfolio reflection, and question and answer sessions.

Intended Learning Outcomes
C: Personal/Transferable/Employment Skills and Knowledge

Intended Learning Outcomes (ILOs)
On successfully completing this programme you will be able to:		Intended Learning Outcomes (ILOs) will be...
...accommodated and facilitated by the following learning and teaching activities (in/out of class):...and evidenced by the following assessment methods:

11. Communicate effectively and competently with patients, healthcare professionals, professional training placement teams, and lay audiences
12. Manage time, work load, ambiguity, change, and stress effectively
13. Demonstrate effective personal development planning, based on self-awareness and reflection
14. Understand and apply key skills of effective management and leadership

Structured small group learning sessions; lectures; practical laboratory classes; experiential placements; research project or dissertation; independent study and personal tutor feedback

LOs 11-14 will be tested across the core and optional module formative and summative assessment, including essay examinations, short answer and multiple choice tests, written reviews, practical work and projects, quantitative problems, project report/dissertation, oral and poster presentations; project supervisor judgements, and reflective portfolio analyses.

7. Programme Regulations

Assessment at stage one does not contribute to the summative classification of the award. The award will normally be based on the degree mark formed from the credit weighted average marks for stages 2, 3 and 4 combined in the ratio 2:1:4 respectively.

Classification

8. College Support for Students and Students' Learning

All applications are considered individually on merit. The University is committed to an equal opportunities policy with respect to gender, age, race, sexual orientation and/or disability when dealing with applications. It is also committed to widening access to higher education to students from a diverse range of backgrounds and experience. Candidates must satisfy the general admissions requirements of the University of Exeter. ( http://www.exeter.ac.uk/undergraduate/applications/index.html)

9. University Support for Students and Students' Learning

10. Admissions Criteria

All applications are considered individually on merit. The University is committed to an equal opportunities policy with respect to gender, age, race, sexual orientation and/or disability when dealing with applications. It is also committed to widening access to higher education to students from a diverse range of backgrounds and experience. Candidates must satisfy the general admissions requirements of the University of Exeter. ( http://www.exeter.ac.uk/undergraduate/applications/index.html)

11. Regulation of Assessment and Academic Standards

12. Indicators of Quality and Standards

The programme is not subject to accreditation and/ or review by professional and statutory regulatory bodies (PSRBs).

13. Methods for Evaluating and Improving Quality and Standards

14. Awarding Institution

University of Exeter

15. Lead College / Teaching Institution

Faculty of Health and Life Sciences

16. Partner College / Institution

Partner College(s)

Not applicable to this programme

Partner Institution

Not applicable to this programme.

17. Programme Accredited / Validated by

0

18. Final Award

BSc (Hons) Medical Sciences (Neuroscience)

19. UCAS Code

B106

20. NQF Level of Final Award

6 (Honours)

21. Credit

CATS credits

380

 ECTS credits

180

22. QAA Subject Benchmarking Group

23. Dates

Origin Date

01/05/2016

 Date of last revision

08/03/2023